<p>Toby Freyman of Arsenal Medical, Inc. in the U.S. proposes to develop a hemostatic foam device that can be delivered into the uterus to control bleeding following childbirth. Success in this effort will significantly reduce maternal death in the developing world by providing an effective yet simple and inexpensive medical device that is compatible with existing infrastructure.</p>


Toby Freyman of Arsenal Medical, Inc. in the U.S. proposes to develop a hemostatic foam device that can be delivered into the uterus to control bleeding following childbirth. Success in this effort will significantly reduce maternal death in the developing world by providing an effective yet simple and inexpensive medical device that is compatible with existing infrastructure.